Join
Live feed
·
INSIDERFilingvia Quantisnow
Black Diamond Therapeutics Inc. logo

PRESIDENT & CEO Velleca Mark A. was granted 75,000 shares, increasing direct ownership by 161% to 121,522 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
BDTX· Black Diamond Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BDTX (Black Diamond Therapeutics Inc.) and more on Quantisnow.